Solution-phase parallel synthesis of novel membrane-targeted antibiotics

Journal of Combinatorial Chemistry
Sunil K Vooturi, Steven M Firestine

Abstract

The increase in the incidence of antibiotic-resistant infections is a major concern to healthcare workers and requires the development of novel antibacterial agents. Recently, we described a series of benzophenone-containing antibiotics which displayed activity against antibiotic-resistant bacteria. We have shown that these agents function by disrupting the bacterial membrane. To further explore these compounds, a practical and efficient solution-phase parallel synthesis method was developed which allowed us to prepare combinatorial libraries of these agents. Using this method, we prepared 218 compounds in 58 reactions. All of the compounds were characterized by HPLC and MALDI-TOF mass spectrometry. Analysis of this library for antibacterial activity identified six compounds which displayed MIC values of 2.0 mg/L against Staphylococcus aureus. Examination of the structure-function relationships of these agents revealed that cationic groups were required and that cyclic, aliphatic amines were crucial for activity. Using the information generated here, we speculate on how the various structural features of the molecule are necessary for the interaction with the bacterial membrane.

References

Mar 2, 2002·The Lancet Infectious Diseases·K Hiramatsu
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brad SpellbergJohn E Edwards
Oct 23, 2004·The Journal of Infectious Diseases·Heather A CarletonFrançoise Perdreau-Remington
Feb 11, 2005·Nature Reviews. Microbiology·Kim A Brogden
Mar 11, 2005·Expert Opinion on Investigational Drugs·Michael N Alekshun
Sep 13, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·H Lode
Nov 11, 2005·Biochemical Pharmacology·Louis B Rice
Nov 30, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G M Eliopoulos
Mar 10, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P C Appelbaum
Oct 13, 2006·Bioorganic & Medicinal Chemistry·Mi Na JoAe Nim Pae
Jul 3, 2007·Journal of the American Society for Mass Spectrometry·Sarah Trimpin, Max L Deinzer
Aug 10, 2007·Expert Opinion on Investigational Drugs·Roman Jerala
Oct 18, 2007·Langmuir : the ACS Journal of Surfaces and Colloids·Georg PabstJohn Katsaras
Oct 31, 2007·European Biophysics Journal : EBJ·Steven W HoSuzana K Straus
Feb 12, 2008·Trends in Pharmacological Sciences·Françoise Van BambekePaul M Tulkens
Mar 5, 2008·Biopolymers·Abhigyan SomGregory N Tew
Jul 10, 2008·Journal of the American Chemical Society·Ramesh Rathinakumar, William C Wimley

❮ Previous
Next ❯

Citations

Oct 21, 2014·Journal of Helminthology·J E N SousaJ M Costa-Cruz
Dec 14, 2018·MedChemComm·Khemchand SuranaSatyasheel Sharma
Aug 29, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Anna CzopekAgnieszka Zagórska

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.